Table 3.
Total | PHCUs studied | Other PHCUs | p value | |
---|---|---|---|---|
Sociodemographic data | ||||
Sex (% women) | 61.9% | 62% | 61.9% | 0.156 |
Race (% nonwhite) | 55.3% | 57.4% | 54.5% | 0.108 |
Education level | 0.291 | |||
Illiterate | 6.1% | 4.7% | 6.7% | |
Incomplete elementary education | 61.6% | 64.2% | 60.6% | |
Complete elementary education | 15.8% | 15.7% | 15.8% | |
Complete secondary education | 13.8% | 12.7% | 14.3% | |
Complete higher education | 1.9% | 2.2% | 1.8% | |
Clinical data | ||||
Sedentary lifestyle | 21.7% | 22.3% | 21.5% | 0.113 |
Alcohol abuse | 13.7% | 12.5% | 14.1% | 0.562 |
Current smoking | 9.0% | 9.4% | 8.8% | 0.433 |
BMI (mean, kg/m2) | 31,00 | 31,04 | 30,91 | 0.670 |
Controlled BP | 43.9% | 42.8% | 45.5% | 0.202 |
Insulin use | 21% | 24.9% | 19.5% | 0.002 |
Metformin use | 69% | 68.2% | 69.2% | 0.622 |
Sulphonylurea use (%) | 41% | 37.3% | 42.1% | 0.027 |
ACEI/ARB use (%) | 65% | 68.7% | 63.9% | 0.020 |
Statin use (%) | 55% | 58.1% | 53.4% | 0.300 |
Aspirin use (%) | 44% | 47.4% | 42.3% | 0.018 |
Laboratory data | ||||
HbA1c (mean, %) | 9.3 | 9.21 | 9.31 | 0.457 |
LDL (mean, mg/dL) | 116 | 116,71 | 116.17 | 0.848 |
eGFR (mean, mL/min) | 78 | 75.69 | 78.35 | 0.127 |
BMI: body mass index; BP: blood pressure; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; HbA1c: glycated hemoglobin; LDL: LDL cholesterol; eGFR: estimated glomerular filtration rate (MDRD).